AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2021
Apr 20, 2021
34117_dirs_2021-04-20_d0d8517d-eeab-4565-9b13-6cbae27136c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anixa Biosciences Inc (ANIX)
CIK: 0000715446
Period of Report: 2021-04-20
Reporting Person: Baskies Arnold M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-20 | Common Stock | P | 10000 | $3.91 | Acquired | 61000 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6